Escalon Medical Corp. (ESMC) Return on equity 2017–2026
Escalon Medical Corp. (ESMC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
67.7%FY2026 · since FY2017: -61.4% → 67.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 67.7% | +62.2 pp |
| FY2025 | 5.5% | +12.4 pp |
| FY2024 | -6.9% | -30.5 pp |
| FY2023 | 23.6% | +22.4 pp |
| FY2022 | 1.2% | +4.8 pp |
| FY2021 | -3.6% | +39.4 pp |
| FY2020 | -43.0% | -31.4 pp |
| FY2019 | -11.6% | -35.8 pp |
| FY2018 | 24.2% | +85.6 pp |
| FY2017 | -61.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ESMC financial trends
ESMC RevenueESMC Net incomeESMC Net marginESMC Gross profitESMC Gross marginESMC Operating incomeESMC Operating marginESMC Operating cash flowESMC Free cash flowESMC Capital expendituresESMC Stock buybacksESMC Dividends paidESMC Total assetsESMC Total liabilitiesESMC Shareholders’ equityESMC overview →